diagnostic slide session case 8 michelle madden felicella, md juan bilbao, md arie perry, md...
TRANSCRIPT
![Page 1: DIAGNOSTIC SLIDE SESSION CASE 8 Michelle Madden Felicella, MD Juan Bilbao, MD Arie Perry, MD Clinical history, follow-up and MR images kindly provided](https://reader036.vdocuments.mx/reader036/viewer/2022062519/5697bff21a28abf838cbba55/html5/thumbnails/1.jpg)
![Page 2: DIAGNOSTIC SLIDE SESSION CASE 8 Michelle Madden Felicella, MD Juan Bilbao, MD Arie Perry, MD Clinical history, follow-up and MR images kindly provided](https://reader036.vdocuments.mx/reader036/viewer/2022062519/5697bff21a28abf838cbba55/html5/thumbnails/2.jpg)
DIAGNOSTIC SLIDE SESSION CASE 8
Michelle Madden Felicella, MDJuan Bilbao, MDArie Perry, MD
Clinical history, follow-up and MR images kindly provided by Dr. Todd Mainprize
![Page 3: DIAGNOSTIC SLIDE SESSION CASE 8 Michelle Madden Felicella, MD Juan Bilbao, MD Arie Perry, MD Clinical history, follow-up and MR images kindly provided](https://reader036.vdocuments.mx/reader036/viewer/2022062519/5697bff21a28abf838cbba55/html5/thumbnails/3.jpg)
CLINICAL HISTORY
• 42-yo woman with headache and left transverse sinus occlusion
• Treated with warfarin and followed by neurology
• MRI: prominent dural thickening and nodularity of cerebral hemispheres including the falx and tentorium
• Repeat MRI a few months later: worsened thickening
• Referred to neurosurgery for biopsy of the left temporal lobe
![Page 4: DIAGNOSTIC SLIDE SESSION CASE 8 Michelle Madden Felicella, MD Juan Bilbao, MD Arie Perry, MD Clinical history, follow-up and MR images kindly provided](https://reader036.vdocuments.mx/reader036/viewer/2022062519/5697bff21a28abf838cbba55/html5/thumbnails/4.jpg)
![Page 5: DIAGNOSTIC SLIDE SESSION CASE 8 Michelle Madden Felicella, MD Juan Bilbao, MD Arie Perry, MD Clinical history, follow-up and MR images kindly provided](https://reader036.vdocuments.mx/reader036/viewer/2022062519/5697bff21a28abf838cbba55/html5/thumbnails/5.jpg)
![Page 6: DIAGNOSTIC SLIDE SESSION CASE 8 Michelle Madden Felicella, MD Juan Bilbao, MD Arie Perry, MD Clinical history, follow-up and MR images kindly provided](https://reader036.vdocuments.mx/reader036/viewer/2022062519/5697bff21a28abf838cbba55/html5/thumbnails/6.jpg)
![Page 7: DIAGNOSTIC SLIDE SESSION CASE 8 Michelle Madden Felicella, MD Juan Bilbao, MD Arie Perry, MD Clinical history, follow-up and MR images kindly provided](https://reader036.vdocuments.mx/reader036/viewer/2022062519/5697bff21a28abf838cbba55/html5/thumbnails/7.jpg)
![Page 8: DIAGNOSTIC SLIDE SESSION CASE 8 Michelle Madden Felicella, MD Juan Bilbao, MD Arie Perry, MD Clinical history, follow-up and MR images kindly provided](https://reader036.vdocuments.mx/reader036/viewer/2022062519/5697bff21a28abf838cbba55/html5/thumbnails/8.jpg)
![Page 9: DIAGNOSTIC SLIDE SESSION CASE 8 Michelle Madden Felicella, MD Juan Bilbao, MD Arie Perry, MD Clinical history, follow-up and MR images kindly provided](https://reader036.vdocuments.mx/reader036/viewer/2022062519/5697bff21a28abf838cbba55/html5/thumbnails/9.jpg)
![Page 10: DIAGNOSTIC SLIDE SESSION CASE 8 Michelle Madden Felicella, MD Juan Bilbao, MD Arie Perry, MD Clinical history, follow-up and MR images kindly provided](https://reader036.vdocuments.mx/reader036/viewer/2022062519/5697bff21a28abf838cbba55/html5/thumbnails/10.jpg)
![Page 11: DIAGNOSTIC SLIDE SESSION CASE 8 Michelle Madden Felicella, MD Juan Bilbao, MD Arie Perry, MD Clinical history, follow-up and MR images kindly provided](https://reader036.vdocuments.mx/reader036/viewer/2022062519/5697bff21a28abf838cbba55/html5/thumbnails/11.jpg)
![Page 12: DIAGNOSTIC SLIDE SESSION CASE 8 Michelle Madden Felicella, MD Juan Bilbao, MD Arie Perry, MD Clinical history, follow-up and MR images kindly provided](https://reader036.vdocuments.mx/reader036/viewer/2022062519/5697bff21a28abf838cbba55/html5/thumbnails/12.jpg)
![Page 13: DIAGNOSTIC SLIDE SESSION CASE 8 Michelle Madden Felicella, MD Juan Bilbao, MD Arie Perry, MD Clinical history, follow-up and MR images kindly provided](https://reader036.vdocuments.mx/reader036/viewer/2022062519/5697bff21a28abf838cbba55/html5/thumbnails/13.jpg)
DIAGNOSIS???
![Page 14: DIAGNOSTIC SLIDE SESSION CASE 8 Michelle Madden Felicella, MD Juan Bilbao, MD Arie Perry, MD Clinical history, follow-up and MR images kindly provided](https://reader036.vdocuments.mx/reader036/viewer/2022062519/5697bff21a28abf838cbba55/html5/thumbnails/14.jpg)
EMA EMA
![Page 15: DIAGNOSTIC SLIDE SESSION CASE 8 Michelle Madden Felicella, MD Juan Bilbao, MD Arie Perry, MD Clinical history, follow-up and MR images kindly provided](https://reader036.vdocuments.mx/reader036/viewer/2022062519/5697bff21a28abf838cbba55/html5/thumbnails/15.jpg)
CD3 CD20
![Page 16: DIAGNOSTIC SLIDE SESSION CASE 8 Michelle Madden Felicella, MD Juan Bilbao, MD Arie Perry, MD Clinical history, follow-up and MR images kindly provided](https://reader036.vdocuments.mx/reader036/viewer/2022062519/5697bff21a28abf838cbba55/html5/thumbnails/16.jpg)
Kappa Lambda
![Page 17: DIAGNOSTIC SLIDE SESSION CASE 8 Michelle Madden Felicella, MD Juan Bilbao, MD Arie Perry, MD Clinical history, follow-up and MR images kindly provided](https://reader036.vdocuments.mx/reader036/viewer/2022062519/5697bff21a28abf838cbba55/html5/thumbnails/17.jpg)
IgG4IgG
![Page 18: DIAGNOSTIC SLIDE SESSION CASE 8 Michelle Madden Felicella, MD Juan Bilbao, MD Arie Perry, MD Clinical history, follow-up and MR images kindly provided](https://reader036.vdocuments.mx/reader036/viewer/2022062519/5697bff21a28abf838cbba55/html5/thumbnails/18.jpg)
SPECIAL STAINS• CD3, CD5: numerous reactive T-cells• CD20, CD21, CD23, CD10, BCL6: small lymphocytes in
germinal centers• BCL2: positive in scattered interstitial small lymphocytes• Cyclin D1: negative• EMA: positive in meningothelial cells (limited to surface)
and numerous plasma cells• ISH for kappa and lambda: polyclonal• Ki-67: moderate LI• IgG4: 80 plasma cells/HPF• IgG4/IgG: 15%
![Page 19: DIAGNOSTIC SLIDE SESSION CASE 8 Michelle Madden Felicella, MD Juan Bilbao, MD Arie Perry, MD Clinical history, follow-up and MR images kindly provided](https://reader036.vdocuments.mx/reader036/viewer/2022062519/5697bff21a28abf838cbba55/html5/thumbnails/19.jpg)
DIAGNOSIS
• Chronic pachymeningitis with meningothelial proliferation and increased IgG4-positive plasma cells
• Most likely represent IgG4 sclerosing disease and meningothelial hyperplasia
![Page 20: DIAGNOSTIC SLIDE SESSION CASE 8 Michelle Madden Felicella, MD Juan Bilbao, MD Arie Perry, MD Clinical history, follow-up and MR images kindly provided](https://reader036.vdocuments.mx/reader036/viewer/2022062519/5697bff21a28abf838cbba55/html5/thumbnails/20.jpg)
![Page 21: DIAGNOSTIC SLIDE SESSION CASE 8 Michelle Madden Felicella, MD Juan Bilbao, MD Arie Perry, MD Clinical history, follow-up and MR images kindly provided](https://reader036.vdocuments.mx/reader036/viewer/2022062519/5697bff21a28abf838cbba55/html5/thumbnails/21.jpg)
![Page 22: DIAGNOSTIC SLIDE SESSION CASE 8 Michelle Madden Felicella, MD Juan Bilbao, MD Arie Perry, MD Clinical history, follow-up and MR images kindly provided](https://reader036.vdocuments.mx/reader036/viewer/2022062519/5697bff21a28abf838cbba55/html5/thumbnails/22.jpg)
DIAGNOSTIC POINTS• Differential diagnosis:
• Lymphoplasmacyte rich meningioma• Idiopathic hypertrophic pachymeningitis• Lymphoproliferative disorder• IgG4-related hypertrophic pachymeningitisIgG4-related hypertrophic pachymeningitis
• Key Histologic features:• Dense lymphoplasmacytic infiltrate with many plasma cells• Storiform Fibrosis• Phlebitis• Scattered eosinophils
• Average count of 5 HPF in the area of greatest concentration:• Our case: 80 IgG4 + cells/HPF and 518 IgG + cells/HPF• IgG4:IgG ratio of 15%.• Normal ratio in serum is <5%• Average IgG4 PCs in other inflammatory conditions <10 HPF
• Differential diagnosis: • Lymphoplasmacyte rich meningioma• Idiopathic hypertrophic pachymeningitis• Lymphoproliferative disorder• IgG4-related hypertrophic pachymeningitisIgG4-related hypertrophic pachymeningitis
• Key Histologic features:• Dense lymphoplasmacytic infiltrate with many plasma cells• Storiform Fibrosis• Phlebitis• Scattered eosinophils
• Average count of 5 HPF in the area of greatest concentration:• Our case: 80 IgG4 + cells/HPF and 518 IgG + cells/HPF• IgG4:IgG ratio of 15%.• Normal ratio in serum is <5%• Average IgG4 PCs in other inflammatory conditions <10 HPF
![Page 23: DIAGNOSTIC SLIDE SESSION CASE 8 Michelle Madden Felicella, MD Juan Bilbao, MD Arie Perry, MD Clinical history, follow-up and MR images kindly provided](https://reader036.vdocuments.mx/reader036/viewer/2022062519/5697bff21a28abf838cbba55/html5/thumbnails/23.jpg)
• Although cut-offs well established in other organ systems, they are not well established for meningeal disease
• Can form a mass or a more diffuse plaque-like growth pattern. More commonly is mass forming in other organs.
• Highly steroid responsive
• Serum IgG4 levels may be helpful in some cases and should be done
• Hyper-eosinophilia also common
DIAGNOSTIC POINTS
![Page 24: DIAGNOSTIC SLIDE SESSION CASE 8 Michelle Madden Felicella, MD Juan Bilbao, MD Arie Perry, MD Clinical history, follow-up and MR images kindly provided](https://reader036.vdocuments.mx/reader036/viewer/2022062519/5697bff21a28abf838cbba55/html5/thumbnails/24.jpg)
FOLLOW-UP
• Rx after bx: high dose steroids for about 2 months
• CT scans of neck, chest, abdomen negative for systemic evidence of a lymphoproliferative disorder.
• MRI at 2 months showed significant improvement. She was tapered from steroids subsequently due to side effects. Follow-up MRI scans show continued improvement.
• She is much improved clinically although she still has transverse sinus occlusion and is on warfarin.
![Page 25: DIAGNOSTIC SLIDE SESSION CASE 8 Michelle Madden Felicella, MD Juan Bilbao, MD Arie Perry, MD Clinical history, follow-up and MR images kindly provided](https://reader036.vdocuments.mx/reader036/viewer/2022062519/5697bff21a28abf838cbba55/html5/thumbnails/25.jpg)
PRE-RX
![Page 26: DIAGNOSTIC SLIDE SESSION CASE 8 Michelle Madden Felicella, MD Juan Bilbao, MD Arie Perry, MD Clinical history, follow-up and MR images kindly provided](https://reader036.vdocuments.mx/reader036/viewer/2022062519/5697bff21a28abf838cbba55/html5/thumbnails/26.jpg)
POST-RX
![Page 27: DIAGNOSTIC SLIDE SESSION CASE 8 Michelle Madden Felicella, MD Juan Bilbao, MD Arie Perry, MD Clinical history, follow-up and MR images kindly provided](https://reader036.vdocuments.mx/reader036/viewer/2022062519/5697bff21a28abf838cbba55/html5/thumbnails/27.jpg)
REFERENCES
• Smyrk TC. Pathological features of IgG4-related sclerosing disease. Curr Opin Rheumatol 2011;23(1):74-9.
• Cheuk W, Chan JK. IgG4-related sclerosing disease: a critical appraisal of an evolving clinicopathologic entity. Adv Anat Pathol 2010;17(5):303-32.
• Lindstrom KM, Cousar JB, Lopes MB. IgG4-related meningeal disease: clinico-pathological features and proposal for diagnostic criteria. Acta Neuropathol 2010;120(6):765-76.
• Stone JH, Zen Y, Deshpande V. IgG4 related disease. N Engl J Med 2012;366:539-51.
![Page 28: DIAGNOSTIC SLIDE SESSION CASE 8 Michelle Madden Felicella, MD Juan Bilbao, MD Arie Perry, MD Clinical history, follow-up and MR images kindly provided](https://reader036.vdocuments.mx/reader036/viewer/2022062519/5697bff21a28abf838cbba55/html5/thumbnails/28.jpg)